Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

SER holding history

Serina Therapeutics, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SER overviewAll 13F holders of SERFull Q4 2025 holdings

Shares (Q4 2025)
180,013
Value
$344.4K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of SER by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 2025180,013$344.4K<0.1%00.0%UnchangedHolders
Q3 2025180,013$964.9K<0.1%+29,390+19.5%AddedHolders
Q2 2025150,623$927.8K<0.1%+85,290+130.5%AddedHolders
Q1 202565,333$370.4K<0.1%+3,260+5.3%AddedHolders
Q4 202462,073$311.0K<0.1%+17,573+39.5%AddedHolders
Q3 202444,500$297.7K<0.1%+22,368+101.1%AddedHolders
Q2 202422,132$212.0K<0.1%+2,181+10.9%AddedHolders
Q1 202419,951$268.5K<0.1%00.0%UnchangedConverted for a 1-for-35 splitHolders
Q4 2023701,755$270.2K<0.1%+3,341+0.5%AddedHolders
Q3 2023698,414$474.9K<0.1%00.0%UnchangedHolders
Q2 2023698,414$623.8K<0.1%00.0%UnchangedHolders
Q1 2023698,414$463.0K<0.1%00.0%UnchangedHolders
Q4 2022698,414$385.5K<0.1%−1,450−0.2%ReducedHolders
Q3 2022699,864$393.0K<0.1%00.0%UnchangedHolders
Q2 2022699,864$403.0K<0.1%−1,156−0.2%ReducedHolders
Q1 2022701,020$599.0K<0.1%+2000.0%AddedHolders
Q4 2021700,820$764.0K<0.1%00.0%UnchangedHolders
Q3 2021700,820$659.0K<0.1%+8,943+1.3%AddedHolders
Q2 2021691,877$1.07M<0.1%00.0%UnchangedHolders
Q1 2021691,877$1.12M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.